0001237899-20-000023.txt : 20200609 0001237899-20-000023.hdr.sgml : 20200609 20200609160530 ACCESSION NUMBER: 0001237899-20-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200608 FILED AS OF DATE: 20200609 DATE AS OF CHANGE: 20200609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L CENTRAL INDEX KEY: 0001225474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20951853 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-06-08 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001225474 GOLDSTEIN JOSEPH L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-06-08 4 M 0 3000 413.33 A 9643 D Common Stock 2020-06-08 4 M 0 3000 413.33 A 12643 D Common Stock 2020-06-08 4 M 0 4838 413.33 A 17481 D Common Stock 2020-06-08 4 S 0 100 580.65 D 17381 D Common Stock 2020-06-08 4 S 0 200 582.31 D 17181 D Common Stock 2020-06-08 4 S 0 1175 583.67 D 16006 D Common Stock 2020-06-08 4 S 0 200 585.58 D 15806 D Common Stock 2020-06-08 4 S 0 300 587.2 D 15506 D Common Stock 2020-06-08 4 S 0 3200 587.88 D 12306 D Common Stock 2020-06-08 4 S 0 200 589.87 D 12106 D Common Stock 2020-06-08 4 S 0 100 590.47 D 12006 D Common Stock 2020-06-08 4 S 0 60 592.46 D 11946 D Common Stock 2020-06-08 4 S 0 700 595.31 D 11246 D Common Stock 2020-06-08 4 S 0 1111 596.47 D 10135 D Common Stock 2020-06-08 4 S 0 771 597.51 D 9364 D Common Stock 2020-06-08 4 S 0 200 598.07 D 9164 D Common Stock 2020-06-08 4 S 0 200 600.12 D 8964 D Common Stock 2020-06-08 4 S 0 400 601.29 D 8564 D Common Stock 2020-06-08 4 S 0 1196 602.7 D 7368 D Common Stock 2020-06-08 4 S 0 525 603.82 D 6843 D Common Stock 2020-06-08 4 S 0 200 604.49 D 6643 D Non-Qualified Stock Option (right to buy) 413.33 2020-06-08 4 M 0 3000 0.0 D 2025-01-02 Common Stock 3000 7838 D Non-Qualified Stock Option (right to buy) 413.33 2020-06-08 4 M 0 3000 0.0 D 2025-01-02 Common Stock 3000 4838 D Non-Qualified Stock Option (right to buy) 413.33 2020-06-08 4 M 0 4838 0.0 D 2025-01-02 Common Stock 4838 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $581.98 to $582.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 1,175 shares of Company stock on June 8, 2020 at prices ranging from $583.15 to $584.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $585.75 to $585.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on June 8, 2020 at prices ranging from $586.80 to $587.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 3,200 shares of Company stock on June 8, 2020 at prices ranging from $587.88 to $587.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $589.41 to $590.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 700 shares of Company stock on June 8, 2020 at prices ranging from $594.86 to $595.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 1,111 shares of Company stock on June 8, 2020 at prices ranging from $595.91 to $596.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 771 shares of Company stock on June 8, 2020 at prices ranging from $597.04 to $597.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $599.66 to $600.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 400 shares of Company stock on June 8, 2020 at prices ranging from $600.85 to $601.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 1,196 shares of Company stock on June 8, 2020 at prices ranging from $602.15 to $603.00. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 525 shares of Company stock on June 8, 2020 at prices ranging from $603.25 to $604.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $604.40 to $604.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Joseph L. Goldstein 2020-06-09